Breaking News | YHLO Achieves Full IVDR CE Certification for the Blood Bank Panel 🎉— the First in China 🇨🇳🌍
Breaking News!!! We are thrilled to share a major milestone in YHLO's global regulatory journey that we have got the latest Class D IVDR CE certificate for our HIV assay! With this approval, YHLO has now achieved full IVDR CE certification for the entire Blood Bank Panel—including HIV, HBV(HBsAg, Anti-HBs, HBeAg, Anti-HBe, Anti-HBc), HCV, and Syphilis(Anti-TP).
This achievement makes YHLO the first company in China — and among the first globally — to obtain full IVDR CE certification for the Blood Bank panel.
Founded in 2008, YHLO is a national high-tech enterprise and specialized in R&D, production and sale of in vitro diagnostic (IVD) instruments and reagents. With our committed innovation, nowadays our multiple products have entered more than 120 countries.
YHLO will continue working hand-in-hand with glogal partners to build a healthier, better future together.
Attachments:
Previous
MORE NEWS
China-Hospeq 2026: YHLO Brings Diagnostic Solutions to Global Health Partners
YHLO Brings Diagnostic Solutions to Global Health Partners at China-Hospeq 2026
2026-08-20
ADLM 2026: YHLO Brings Proven Lab Automation to the Americas
YHLO showcases its innovative products and academic achievements at ADLM 2026.
2026-08-01
Add: Building 1, YHLO Biopark, Baolong 2nd Road, Baolong Subdistrict, Longgang District, 518116 Shenzhen, P.R.China
